FDA Authorizes Clinical Trial for CRISPR/Cas9 Therapy for LCA 10

Editas Medicine, a company developing gene-editing treatments, has received authorization from the US Food and Drug Administration to launch a clinical trial for its emerging CRISPR/Cas9 therapy for people with a mutation in the gene CEP290, which causes Leber congenital amaurosis 10 (LCA10). LCA causes severe vision loss or blindness at birth. Known as EDIT-101, the treatment will be evaluated in a Phase 1/2, dose-escalation clinical trial.  The company expects to enroll 10 to 20 patients. Further details and contact information for the study will be listed soon at www.clinicaltrials.gov. EDIT-101 targets a specific mutation, “c.2991+1655A>G” in intron 26, of the CEP290 gene. Editas has earned a $25 million milestone payment from Allergan as part of a drug-development alliance. “We are very pleased with this historic milestone in the treatment of inherited retinal diseases,” says Stephen Rose, PhD, chief scientific officer, Foundation Fighting Blindness. “EDIT-101 is the first gene-editing therapy using CRISPR/Cas9 to move into a human study for a retinal disease. The approach shows great promise for treating these vision-robbing diseases.” CRISPR/Cas9 is the acronym for: Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated 9. The technology is engineered to locate the disease-causing genetic defect. It then works like molecular scissors to cut out the mutated portion of the gene. In some cases, it also inserts a healthy piece of DNA. CRISPR/Cas9 is different from gene therapy. In gene therapy, copies of a whole new gene are delivered to replace the defective copies of the gene. CRISPR/Cas9, on the other hand, is a “cut-and-paste” approach to fixing the patient’s own mutated gene. One big advantage of CRISPR is getting around the problem of delivering large replacement genes — CEP290 and USH2A, for example — that won’t fit in the human-engineered viruses designed to carry them into retinal cells. Editas is also developing a CRISPR/Cas9 therapy for USH2A, mutations in which can cause Usher syndrome type 2A (combined blindness and deafness) and retinitis pigmentosa. You can learn about Foundation-funded CRISPR/Cas9 projects by going to the blog post: ARVO 2018: Dr. Steve Rose Reports on CRISPR/Cas9 for Inherited Retinal Diseases.
 

https://www.lvcenter4sight.com/fda-authorizes-clinical-trial-for-crispr-cas9-therapy-for-lca-10/

Comments

Post a Comment

Popular posts from this blog

Post-LASIK Refraction and Pregnancy – Much Ado About Nothing?

Image
Written by Dr. David Evans Last modified on August 23, 2018 During pregnancy, women experience a drastic shift in their hormonal balance that has a ripple effect throughout the body. The spike in hormones like progesterone, estrogen, prolactin, oxytocin and relaxin are all important for a healthy pregnancy, but these increased levels can also impact gastrointestinal processes, blood pressure, skin pigmentation and, you guessed it, ocular health. Due to refractive changes that often occur during pregnancy, most refractive surgeons advise against LASIK during pregnancy, instead suggesting women wait several months after giving birth before considering treatment. Women who have already undergone LASIK may then wonder if the changes in ocular health that can occur during and after pregnancy impact post-LASIK refraction. New research presented by John Kanellopoulos, MD, New York University Medical School, NY, and LaserVision.gr seems to throw cold water on any such concern. The Eyes an
Read more

I Spy a Stye in Your Eye

Image
Written by Dr. David Evans Last modified on August 6, 2018 What’s that small, red, pimple-like bump on your eyelid that’s causing so much discomfort? It’s probably a stye (sometimes referred to as a sty or hordeolum). Besides being difficult to say 5 times quickly, an eye stye is a type of localized infection that can occur along the base of your eyelashes or underneath your eyelid. Styes that form along the base of the eyelashes are called external styes. They typically occur as a result of an infected eyelash hair follicle and look like the type of pimple that occurs when your pores are clogged with dirt and oil. Styes that form inside the eyelid are called internal styes. Similar to external styes, they are caused by an infection of an oil-producing gland behind the eyelid rather than an eyelash hair follicle. Internal styes result in generalized swelling of the eyelid rather than forming a pimple-like bump. Stye Symptoms As a stye develops, you might begin to experience pain
Read more

Overuse of Contact Lenses

Image
How do make sure you aren’t overusing your lenses? Most people who have prescription eye glasses prefer wearing contact lenses. It’s not only comfortable but it also doesn’t alter your natural look. Though contact lenses are convenient they shouldn’t be used extensively. Overuse of contact lenses can cause serious damages to your eye. If you are not following the 18 hour week rule, then you could be overusing your contact lenses. In other words you must take out your contact lenses for at least 18 hours a week. Here are some symptoms which are indications that you are using you have your lenses on longer than you should, and you need to consult your eye doctor immediately: Pain and redness in the eye Itching when you remove your lenses Increased mucous secretion in the eye Decreased vision Photophobia or light sensitivity Tearing Inability to remove your lenses because they are stuck in the eye   Your eye needs direct oxygen to ‘breathe’ and remain healthy.
Read more